Nuveen
STIM icon

Nuveen’s Neuronetics STIM Stock Holding History

Nuveen’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-123,089
Closed -$178K – 3843
2026
Q1 		$178K Buy
123,089
+76,046
+162% +$121K ﹤0.01% 3121
2025
Q4 		$64.9K Hold
47,043
– – ﹤0.01% 3227
2025
Q3 		$128K Hold
47,043
– – ﹤0.01% 3209
2025
Q2 		$164K Buy
+47,043
New +$186K ﹤0.01% 3192
2022
Q2 		– Sell
-79,147
Closed -$264K – 3467
2022
Q1 		$264K Buy
79,147
+11
+0% +$37 ﹤0.01% 3146
2021
Q4 		$314K Sell
79,136
-7,849
-9% -$38.4K ﹤0.01% 3170
2021
Q3 		$560K Sell
86,985
-964
-1% -$9.25K ﹤0.01% 3148
2021
Q2 		$1.41M Buy
+87,949
New +$1.22M ﹤0.01% 2869
2020
Q2 		– Sell
-35,190
Closed -$66K – 3358
2020
Q1 		$66K Buy
35,190
+270
+0.8% +$844 ﹤0.01% 3093
2019
Q4 		$157K Sell
34,920
-1,777
-5% -$11K ﹤0.01% 3094
2019
Q3 		$305K Hold
36,697
– – ﹤0.01% 3046
2019
Q2 		$459K Buy
+36,697
New +$519K ﹤0.01% 3034

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuveen's STIM Position: Q2 2026 in Review

Nuveen sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 123,089 shares — an estimated $178K sold.

Nuveen first reported a position in STIM in Q2 2019 and held it in 12 quarters. The position peaked at $1.41M in Q2 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Nuveen reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 123,089 Neuronetics shares in Q2 2026, an estimated $178K.
  • Nuveen first reported a position in Neuronetics in Q2 2019 and held it in 12 quarters.
  • Nuveen's Neuronetics position peaked at $1.41M in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.